Performances of Elasto-Fibrotest®, a Combination Between Fibrotest and Liver Stiffness Measurements for Assessing the Stage of Liver Fibrosis in Patients With Chronic Hepatitis C

Poynard, Thierry; Lédinghen, Victor de; Zarski, Jean–Pierre; Stanciu, C; Munteanu, Mona; Vergniol, Julien; France, J.; Trifan, Anca; Lenaour, Gilles; Vaillant, Jean Christophe; Ratziu, Vlad; Charlotte, F.

doi:10.1016/s0168-8278(12)61075-7

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2014

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The low reliability rate and the interobserver variability are major weaknesses of transient elastography compared to blood tests. FibroTest (FibroSURE LabCorp, Burlington, NC, USA) is the most validated biomarker for the non-invasive assessment of fibrosis stages in patients with chronic hepatitis C. The combination of FibroTest and transient elastography (Elasto-FibroTest) has significantly higher performances for cirrhosis diagnosis than FibroTest or transient elastography alone (33). The association of biomarkers with transient elastography would minimize the limitations of transient elastography and could be useful in clinical practice.…”

Section: Discussionmentioning

confidence: 99%